Search Results - "Gozansky, W."

Refine Results
  1. 1

    Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity by Gozansky, W. S., Lynn, J. S., Laudenslager, M. L., Kohrt, W. M.

    Published in Clinical endocrinology (Oxford) (01-09-2005)
    “…Summary Objective  The aim of this study was to determine whether salivary cortisol measured by a simple enzyme immunoassay (EIA) could be used as a surrogate…”
    Get full text
    Journal Article
  2. 2

    Lower-Body Adiposity and Metabolic Protection in Postmenopausal Women by Van Pelt, R. E., Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., Kohrt, W. M.

    “…Context: It has been suggested that the propensity to store fat in the gluteal-femoral region may be cardioprotective. Objective: The primary aim of this study…”
    Get full text
    Journal Article
  3. 3

    Estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes by Pelt, R.E., Gozansky, W.S., Wolfe, P., Kittelson, J.M., Jankowski, C.M., Schwartz, R.S., Kohrt, W.M.

    Published in Obesity (Silver Spring, Md.) (01-04-2014)
    “…Objective Estrogen‐based hormone therapy (HT) attenuates abdominal fat gain after menopause, but whether HT improves abdominal fat loss during weight loss is…”
    Get full text
    Journal Article
  4. 4

    Intravenous estrogens increase insulin clearance and action in postmenopausal women by Van Pelt, R E, Gozansky, W S, Schwartz, R S, Kohrt, W M

    “…To test the hypothesis that estrogens alter insulin action, we evaluated the effects of intravenous conjugated estrogens (CE) on insulin-stimulated…”
    Get more information
    Journal Article
  5. 5

    Protection of Bone Mass by Estrogens and Raloxifene during Exercise-Induced Weight Loss by Gozansky, W. S., Van Pelt, R. E., Jankowski, C. M., Schwartz, R. S., Kohrt, W. M.

    “…The aim of this study was to determine whether estrogen and/or raloxifene help to conserve bone mineral density (BMD) during moderate weight loss…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Effects of estrogen replacement on metabolic factors that influence physical performance in female hypogonadism by Kohrt, W M, Van Pelt, R E, Gozansky, W S

    Published in Journal of endocrinological investigation (01-09-2003)
    “…There is a lack of knowledge regarding the effects of estrogens on physical performance. This is related, in part, to the challenge of isolating the effects of…”
    Get full text
    Journal Article
  9. 9

    Loss of bone strength in response to exercise-induced weight loss in obese postmenopausal women: results from a pilot study by Shea, K L, Gozansky, W S, Sherk, V D, Swibas, T A, Wolfe, P, Scherzinger, A, Stamm, E, Kohrt, W M

    “…Exercise-induced weight loss (WL) can lead to decreased areal bone mineral density (aBMD). It is unknown whether this translates into decreased volumetric BMD…”
    Get full text
    Journal Article
  10. 10

    Possible Heart Failure Exacerbation Associated with Rosiglitazone: Case Report and Literature Review by II, Robert Lee Page, Gozansky, Wendolyn S., Ruscin, J. Mark

    Published in Pharmacotherapy (01-07-2003)
    “…Increasing evidence suggests that neurohumoral manifestations of heart failure may lead to insulin resistance, predisposing patients with heart failure to the…”
    Get full text
    Journal Article
  11. 11

    Effects of oral contraceptives on glucoregulatory responses to exercise by Jankowski, Catherine M, Ben-Ezra, Vic, Gozansky, Wendolyn S, Scheaffer, Suzanne E

    Published in Metabolism, clinical and experimental (01-03-2004)
    “…Some of the effects of oral contraceptives (OCs) to alter glucoregulation may be ameliorated by exercise. To test this premise, the effects of acute aerobic…”
    Get full text
    Journal Article
  12. 12

    Prevention practices for perinatal group B streptococcal disease: A multi-state surveillance analysis by Whitney, Cynthia G., Plikaytis, Brian D., Gozansky, Wendolyn S., Wenger, Jay D., Schuchat, Anne

    “…To evaluate hospital-based practices for perinatal group B streptococcal disease prevention and to identify institutional factors related to the disease. We…”
    Get full text
    Journal Article
  13. 13

    A Practical Tool to Identify Patients Who May Benefit from a Palliative Approach: The CARING Criteria by Fischer, Stacy M., Gozansky, Wendolyn S., Sauaia, Angela, Min, Sung-Joon, Kutner, Jean S., Kramer, Andrew

    Published in Journal of pain and symptom management (01-04-2006)
    “…Palliative care is often offered only late in the course of disease after curative measures have been exhausted. To provide timelier symptom management,…”
    Get full text
    Journal Article
  14. 14

    Estrogen or Raloxifene during Postmenopausal Weight Loss: Adiposity and Cardiometabolic Outcomes by Van Pelt, R E, Gozansky, W S, Wolfe, P, Kittelson, J M, Jankowski, C M, Schwartz, R S, Kohrt, W M

    Published in Obesity (Silver Spring, Md.) (01-04-2014)
    “…Estrogen-based hormone therapy (HT) attenuates abdominal fat gain after menopause, but whether HT improves abdominal fat loss during weight loss is unknown. It…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Bisphosphonate Drug Holiday and Fracture Risk: A Population‐Based Cohort Study by Adams, Annette L, Adams, John L, Raebel, Marsha A, Tang, Beth T, Kuntz, Jennifer L, Vijayadeva, Vinutha, McGlynn, Elizabeth A, Gozansky, Wendolyn S

    Published in Journal of bone and mineral research (01-07-2018)
    “…ABSTRACT Holidays from bisphosphonates (BPs) may help to prevent rare adverse events such as atypical femoral fractures, but may be appropriate only if risk of…”
    Get full text
    Journal Article
  19. 19
  20. 20